PAXIL

This brand name is authorized in Brazil, Canada, Ecuador, Japan, Mexico, Turkey, United States, South Africa

Active ingredients

The drug PAXIL contains one active pharmaceutical ingredient (API):

1 Paroxetine UNII X2ELS050D8 - PAROXETINE HYDROCHLORIDE

Paroxetine is a potent and selective inhibitor of 5-hydroxytryptamine (5-HT, serotonin) uptake and its antidepressant action and effectiveness in the treatment of OCD, Social Anxiety disorder/Social Phobia, General Anxiety Disorder, Post-Traumatic Stress Disorder and Panic Disorder is thought to be related to its specific inhibition of 5-HT uptake in brain neurones. Read about Paroxetine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
PAXIL Film‑coated tablet / Oral suspension	FDA, National Drug Code (US)	MPI, US: SPL/Old

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N06AB05	Paroxetine	N Nervous system → N06 Psychoanaleptics → N06A Antidepressants → N06AB Selective serotonin reuptake inhibitors
Discover more medicines within N06AB05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 510609902112214, 510609904115210, 510617060056803, 510617060056903, 510617060057003
Country: CA	Health Products and Food Branch	Identifier(s): 01940473, 01940481, 02027887, 02248503, 02248504
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 25.041-04-03, 29300-07-10, 29367-09-10, 5847-MEE-0121
Country: JP	医薬品医療機器総合機構	Identifier(s): 1179041F1025, 1179041F2021, 1179041F3028, 1179041G1020, 1179041G2027, 1179041G3023
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 008M93, 511M2004
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699522092802, 8699522096947
Country: US	FDA, National Drug Code	Identifier(s): 60505-0402, 60505-3663, 60505-3664, 60505-3665, 60505-3666, 60505-3668, 60505-3669, 60505-3670, 60505-4377, 60505-4378, 60505-4379, 60505-4517, 60505-4518, 60505-4519, 60505-4520, 70518-2500, 70518-2636, 71335-0572
Country: ZA	Health Products Regulatory Authority	Identifier(s): A39/1.2/0078